Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field

Linda A Gonder-Frederick1, John F Zrebiec, Andrea U Bauchowitz

  • 1Behavioral Medicine Center, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia Health Sciences Center, Charlottesville, Virgina, USA. Linda Gonder-Frederick, lag3g@virginia.edu

Diabetes Care
|March 28, 2009
PubMed

Insights

Cognitive function in children with type 1 diabetes declines during both hypoglycemia and hyperglycemia. This study used personal digital assistant (PDA) technology to detect these changes in mental efficiency during glucose fluctuations.

Area of Science:

  • Pediatric Endocrinology
  • Neuroscience
  • Diabetes Management

Background:

  • Type 1 diabetes (T1D) management requires careful blood glucose control.
  • Hypoglycemia and hyperglycemia can impact cognitive function, but real-world data in children is limited.
  • Previous studies often relied on laboratory settings, not reflecting daily fluctuations.

Purpose of the Study:

  • To develop and validate a field procedure using personal digital assistant (PDA) technology to assess cognitive function in children with T1D.
  • To test the hypothesis that naturally occurring hypo- and hyperglycemic episodes are associated with cognitive deterioration.
  • To quantify the impact of glucose extremes on specific cognitive tasks.

Main Methods:

  • A cohort of 61 children (aged 6-11 years) with T1D used PDAs for 4-6 weeks.
  • PDAs administered brief cognitive tests (mental math, choice reaction time) before home glucose monitoring.
  • Performance metrics (completion time, accuracy) and glucose levels were recorded; individual impairment scores (IISs) were calculated.

Main Results:

  • Cognitive performance, specifically task completion time, significantly worsened during both hypoglycemia and hyperglycemia.
  • Mental math performance decline was equivalent at glucose levels below 3.0 mmol/l and above 22.2 mmol/l.
  • No significant differences were observed in task accuracy, indicating slowed processing rather than errors.

Conclusions:

  • Naturally occurring blood glucose fluctuations in children with T1D are associated with measurable declines in mental efficiency.
  • PDA technology provides a feasible method for detecting cognitive effects of glucose variability in a real-world setting.
  • Hyperglycemia above 22.2 mmol/l can impair cognitive function as much as significant hypoglycemia in this population.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...